New oral drug targets Cancer's growth engine in advanced tumours
Disease control
Completed
This trial investigates an experimental oral drug, LY3143921 hydrate, which blocks a protein called Cdc7 that cancer cells need to divide. It is being tested in adults with advanced solid tumours, including colorectal, ovarian, lung, and pancreatic cancers, that have not responde…
Phase: PHASE1 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC